510(k) Report

510(k) · Cleared

Cleared

Abuscreen Online (R) for Amphetamines, Modified

K933052510(k) TraditionalCleared Sep 15, 1993112-day reviewClass II21 CFR 862.3100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostic Systems, Inc. · DKZ Enzyme Immunoassay, Amphetamine

Cleared on Sep 15, 1993 after a 112-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 25 later devices descend from it.

Decided
Sep 15, 1993
Review
112 days
Class
Class II
Product code
DKZ
Recalls
None
Predicates
0

25 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2000: 2 descendants cleared1998: 1 descendant cleared2010: 2 descendants cleared2006: 2 descendants cleared2004: 1 descendant cleared2011: 3 descendants cleared2012: 1 descendant cleared2013: 2 descendants cleared2014: 3 descendants cleared2018: 2 descendants cleared2015: 2 descendants cleared2021: 2 descendants cleared2025: 1 descendant cleared2026: 1 descendant cleared1990200020102020
  1. This deviceK933052 Abuscreen Online (R) for Amphetamines, ModifiedRoche Diagnostic Systems, Inc. · 1993
  2. Descendant · cites it directly · 14 of its ownK992918 STC Amphetamine-Specific Intercept Micro-Plate Eia, Model 1103IOraSure Technologies, Inc. · 2000
  3. Descendant · cites it directly · 7 of its ownK993208 STC Methamphetamine Intercept Micro-Plate Eia, Model 1104IOraSure Technologies, Inc. · 2000 · Recalled
  4. Descendant · 2 generations on · 6 of its ownK103227 Oratect Oral Fluid Drug Screen DevicesBranan Medical Corporation · 2012
  5. Descendant · 3 generations on · 3 of its ownK171403 OralTox Oral Fluid Drug TestPremier Biotech, Inc. · 2018
  6. Descendant · 2 generations on · 3 of its ownK062242 Methamphetamine Oral Fluid Homogeneous Enzyme Immunoassay…Lin-Zhi International, Inc. · 2006

Showing 5 of 25 descendants. See all descendants

Descendants cleared per year

1998: 12000: 22004: 12006: 22010: 22011: 32012: 12013: 22014: 32015: 22018: 22021: 22025: 12026: 1
1998high 3 (2011) · low 0 (1999)2026

Most influential descendants

Showing 5 of 25 · See all
  • K992918STC Amphetamine-Specific Intercept Micro-Plate Eia, Model 1103IOraSure Technologies, Inc. · 2000 · cites it directly14descendants
  • K993208STC Methamphetamine Intercept Micro-Plate Eia, Model 1104IOraSure Technologies, Inc. · 2000 · cites it directly7descendants
  • K103227Oratect Oral Fluid Drug Screen DevicesBranan Medical Corporation · 2012 · 2 generations on6descendants
  • K171403OralTox Oral Fluid Drug TestPremier Biotech, Inc. · 2018 · 3 generations on3descendants
  • K062242Methamphetamine Oral Fluid Homogeneous Enzyme Immunoassay; Calibrators and ControlsLin-Zhi International, Inc. · 2006 · 2 generations on3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K933052Abuscreen Online (R) for Amphetamines, ModifiedRoche Diagnostic Systems, Inc.1993—
+1K992918STC Amphetamine-Specific Intercept Micro-Plate Eia, Model 1103IOraSure Technologies, Inc.2000—
+1K993208STC Methamphetamine Intercept Micro-Plate Eia, Model 1104IOraSure Technologies, Inc.20001
+2K103227Oratect Oral Fluid Drug Screen DevicesBranan Medical Corporation2012—
+3K171403OralTox Oral Fluid Drug TestPremier Biotech, Inc.2018—
+2K062242Methamphetamine Oral Fluid Homogeneous Enzyme Immunoassay; Calibrators and…Lin-Zhi International, Inc.2006—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199810
200020
200410
200620
201020
201130
201210
201320
201430
201520
201820
202120
202510
202610
FIG. 1 — Lineage of K933052, 1993–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DKZ device

  1. #1 K233019 AllTest Multi-Drug Rapid Test Cup; AllTest…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (25)

See all 25

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K992918STC Amphetamine-Specific Intercept Micro-Plate Eia, Model 1103IOraSure Technologies, Inc.200014
K993208STC Methamphetamine Intercept Micro-Plate Eia, Model 1104IOraSure Technologies, Inc.20007
K983699Modification to Abuscreen Online for AmphetaminesRoche Diagnostic Systems, Inc.19982

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K992918 (OraSure Technologies, Inc., 2000) has gone furthest, with 14 descendants of its own.

How does its category compare?

All DKZ devices

DKZ Enzyme Immunoassay, Amphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DKZ

1in 2024

2008: 22009: 22010: 42011: 62012: 52013: 82014: 82015: 52016: 52018: 32019: 32020: 12023: 22024: 1
2007high 8 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DKZ

180in 2019

2010: 233 days median2011: 123 days median2012: 55 days median2013: 103 days median2014: 128 days median2015: 107 days median2016: 215 days median2018: 128 days median2019: 180 days median
2007high 233 (2010) · low 55 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DKZ

1in 2017

2007: 12008: 32009: 52011: 42013: 12014: 32017: 1
2007high 5 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DKZ

2in 2025

2008: 122009: 12010: 12011: 22013: 12014: 92015: 82016: 82021: 32022: 42023: 72024: 12025: 2
2007high 12 (2008) · low 0 (2007)2025

MAUDE reports naming product code DKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20082—312
20092—51
2010423301
2011612342
201255500
2013810311
2014812839
2015510708
2016521508
20170—10
2018312800
2019318000
20201—00
20210—03
20220—04
20232—07
20241—01
20250—02
20260—0—
Cite this page

510(k) Report. “K933052: Abuscreen Online (R) for Amphetamines, Modified.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K933052

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026